ClinicalTrials.gg
CompletedNCT07941401CPENUpdated Nov 17, 2026

Which One Should Be Preferred In Epidural Neuroplasty?

An observational study in Radiculopathy and Cervical Disk Disease, sponsored by Akdeniz University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Akdeniz University Hospital · Observational

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
75
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 60 studies in Radiculopathy with a site in Turkey — 16 open to participants now, 19 under way, none of them phase 3. Radiculopathy · Turkey.

Enrollment
20th of 27
75 · median 107
Started
2021
with 6 others
Observational
27 of 60
9 open now
Registered
60th of 60
by date
Lead sponsor
1 of 60
Akdeniz University Hospital

Among the 60 studies in Radiculopathy with a site in Turkey, this one is the 20th largest by enrollment of the 27 observational ones that give a count, is one of 7 that started in 2021, is one of 27 observational ones, and was the 60th registered.

Radiculopathy

486 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

Browse Radiculopathy studies →

Open to participants now

16 of the 60 studies in Radiculopathy with a site in Turkey are open now. Recruiting first, the newest first:

11 more — sign in →

All 16 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 80 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 49 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Radiculopathy with a site in Turkey, or all of them as a file.
02

Study summary

Percutaneous Epidural Neuroplasty (PEN) is a minimally invasive treatment option used for the management of back and neck pain.

The investigators aimed to evaluate the effects of different saline concentrations (0.9%, 5%, 10%) used during the cervical PEN procedure on post-procedure NRS and NDI scores.

Read the detailed description

Epidural injections of corticosteroids and local anesthetics (LA) deliver high concentrations of therapeutic agents into the epidural space to inhibit inflammation and reduce nociceptive afferent signaling. The two most common approaches for cervical epidural steroid injections (ESI) are transforaminal (TFESI) and interlaminar (IESI) injections. . Cervical percutaneous epidural neuroplasty (PEN) was derived from lumbar PEN and is utilized as a treatment option for cervical disc herniation.

While different saline concentrations have been evaluated in caudal PEN and transforaminal injections, no study to date has specifically compared different saline concentrations in cervical PEN. In this study, cervical lysis was performed on participants with single-level, unilateral cervical disc herniation. Saline solutions of varying concentrations were administered during the procedure. Therefore, the investigators objective was to compare the impact of different saline concentrations (0.9%, 5%, and 10%) used during the cervical PEN procedure on the procedure's success by evaluating NRS and NDI scores.

Between October 2021 and January 2023, 75 consecutive patients diagnosed with single-level, unilateral cervical disc herniation at the Akdeniz University Algology Clinic were enrolled in the study. Participants. were divided into three groups of 25 individuals each, using a computer-based algorithm for randomization according to the saline concentration to be administered:

  • 10% Group: 10% hypertonic saline
  • 5% Group: 5% saline solution
  • 0.9% Group: 0.9% saline solution
03

Conditions studied

  • Radiculopathy
  • Cervical Disk Disease

Keywords

  • Cervical Percutaneous Epidural Neuroplasty
  • Adhesiolysis
  • Cervical Disc Herniation
  • Hypertonic Saline
  • Neck Pain
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients diagnosed with unilateral cervical disc herniation and treated with cervical lysis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • MRI-confirmed unilateral, single-level cervical disc herniation,
  • Pain complaints consistent with imaging findings,
  • Age 18 years or older,
  • persistent pain lasting longer than three months that has not responded to conservative treatment (medication and physiotherapy), and
  • NRS score of 4 or higher

Exclusion criteria

Exclusion Criteria:

  • Patient refusal,
  • Extruded cervical disc,
  • Spinal stenosis,
  • Motor deficit,
  • Myelomalacia,
  • Discrepancy between MRI findings and clinical presentation,
  • Coagulation disorder, and
  • Any significant psychiatric disorder
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
75 participants (actual)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • %0.9 NACL GROUP

    0.9% NaCl was used in this patient group.

  • %5 NACL GROUP

    5% NaCl was used in this patient group.

  • %10 NACL GROUP

    10% NaCl was used in this patient group.

06

What researchers measure

Primary outcomes

  1. Comparison of the effect of percutaneous cervical epidural neurolysis in the acute phase with baseline NRS scores

    Participants provided a response regarding their pain score, as measured on an NRS scale ranging from 0 (best outcome) to 10 (worst outcome).

    Time frame: 0-1 MOUNTH

  2. Comparison of the effects of different salin concentrations used in cervical epidural neurolysis on NDI and NRS scores

    Participants reported their pain scores at 1, 3, 6, and 12 months using an NRS scale ranging from 0 (best outcome) to 10 (worst outcome), and their disability scores using an NDI scale ranging from 0 (no disability) to 50 (complete disability)..

    Time frame: 1-3-6-12 MOUNTH

07

Study locations

1 site
  • Akdeniz Univercity
    Antalya, 07070, Turkey (Türkiye)
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual patient data will not be shared; statistical results of patient data will be shared.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2021 to primary completion in Jan 2023, 15 months.

Of 41 observational studies under Radiculopathy, half reached primary completion within 75 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 95. This study's 15 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Nov 17, 2026
StartActual
Oct 1, 2021
Primary completionActual
Jan 30, 2023
CompletionActual
Apr 30, 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941401
Lead sponsor
Akdeniz University Hospital
Collaborators
Akdeniz University
Responsible party
gözde dağıstan (ASSOCIATE PROFESSOR ; MEDICINE DOCTOR, Akdeniz University Hospital) — Principal investigator
First posted
Nov 17, 2026
Start date
Oct 1, 2021
Primary completion
Jan 30, 2023
Completion
Apr 30, 2026
Last update
Nov 17, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion